Wireless phone may increase risk of gliomas
the ONA take:
The continual use of a mobile phone increases the odds of developing glioma, an often-fatal brain cancer, according to Swedish researchers. Lead researcher Dr. Lennart Hardell stated that the risk of brain cancer is three times higher after 25 years or more of mobile phone use.
According to the study data, those using a mobile device for less than a year are half as likely to develop glioma when compared to those who reported using a wireless phone for 20 years or more. The effect of mobile use on the likelihood of developing other brain cancers was not examined.
These results contrasted with an earlier study released in 2010, that found no strong evidence of a link between continual mobile device use and increased changes of brain cancer development. The earlier study, financially supported in part by phone companies, is the largest study done on the topic.
The recent study suffers from similar limitations to other case control studies, in that the participants may not always remember their behaviors over a long span of time, which could impact the data. A study conducted in U.S. that examined cell phase use in Californians did however find that the rate of malignant tumors in the area of the brain nearest to where most people hold their phone increased considerably, even as incidence of brain gliomas lowered.
Additional study is warranted.
Risk of brain cancer is three times higher after 25 years or more of mobile phone use.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- Neuropathic Cancer Pain Linked to Reduced Quality of Life
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|